Key result
Gender-specific risk enhancers, including polycystic ovarian syndrome and hypertensive disorders of pregnancy, require tailored primary prevention strategies to reduce cardiovascular disease risk in women.
Why the study?
CVD remains a leading cause of mortality in women, and current methods may not fully capture nuanced female-specific vulnerabilities and risk enhancers that augment CVD risk throughout a woman's life cycle.
This review highlights the importance of incorporating female-specific risk enhancers, such as hypertensive disorders of pregnancy and menopause, into primary cardiovascular disease prevention strategies for women.
Supports incorporating female-specific risks into assessment; leaves open impact on prevention outcomes.
Cardiovascular disease (CVD) remains a leading cause of mortality in women, necessitating innovative primary prevention strategies. Contemporary guidelines on primary prevention of CVD highlight the increasing prevalence of CVD risk factors and emphasize the significance of female-specific risk enhancers that substantially augment the future risk of CVD. These risk factors occur throughout a woman's life cycle, such as hormonal contraception, hypertensive disorders of pregnancy, and menopause, all of which confer an added layer of risk in women beyond the conventional risk factors. Despite this, current methods may not fully capture the nuanced vulnerabilities in women that increase their risk of CVD. In this review, we highlight gender-specific risk enhancers and subsequent prevention as well as strategies to improve primary prevention of CVD in women.
No takes yet. Share an insight, caveat, or question.
Shahid et al. (2024) conducted a review in Cardiovascular Disease. Primary prevention strategies was evaluated. Gender-specific risk enhancers, including polycystic ovarian syndrome and hypertensive disorders of pregnancy, require tailored primary prevention strategies to reduce cardiovascular disease risk in women.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: